AHIP study finds large cost variations in medical care

A survey by America's Health Insurance Plans released Tuesday online finds large price variations common in medical care, according to the New York Times.

AHIP, which represents 1,300 health insurance companies, cited in its study state-by-state comparison of a list of fees billed by out-of-network physicians in the 30 largest states by population. The Times reports: "The group said it had used Medicare payments for comparison because Medicare was so familiar and payments are, on average, about 80 percent of what private insurers pay. The survey, insurers and some economists say, shows the sort of irrational pricing of medical care that is an integral part of the nation's health care problems and that is largely being ignored, some say, in the current debate."

"'It's the wild, wild West when it comes to prices of anything in the U.S. health care system, whether for a doctor visit or for hospital charges,' said Jonathan Skinner, a health economist at Dartmouth."

AHIP's survey comes as "health insurers are trying to defend themselves against recent efforts by the Obama administration to portray certain industry practices as a major part of the nation's health care problems" (Kolata, 8/11).


http://www.kaiserhealthnews.orgThis article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Posted in: Healthcare News

Tags: , , , , , ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Radiotherapy for breast cancer linked to greater risk of second primary lung cancer